Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CVS Health Corp (NY: CVS ) 55.54 -1.53 (-2.68%) Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about CVS Health Corp < Previous 1 2 3 4 5 6 7 8 9 ... 48 49 Next > Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce October 02, 2024 Humana Medicare Advantage plans are getting a big star-ratings cut. Via Investor's Business Daily What Analysts Are Saying About CVS Health Stock October 01, 2024 Via Benzinga CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report October 01, 2024 CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017. Via Benzinga Instacart Is Revolutionizing Groceries: Why It's Time to Invest October 01, 2024 It can be confusing, but Maplebear Inc. (NASDAQ: CART) is better known as Instacart, the world's largest online grocery marketplace. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today September 30, 2024 U.S. markets closed Monday slightly higher, with the Dow Jones Industrial Average edging up 0.04% to 42,330.15. Via Benzinga Topics Stocks Exposures US Equities Stock Of The Day: Is It Time To Sell CVS? September 30, 2024 The chart of CVS (CVS) shows two important market principles. There tends to be resistance at former peaks and support at former bottoms. Via Benzinga CVS Health's Options: A Look at What the Big Money is Thinking September 24, 2024 Via Benzinga CVS Health in Focus as Activist Investor Prepares for High-Level Talks September 30, 2024 CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit. Via Benzinga CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm September 25, 2024 From Bragar Eagel & Squire Via GlobeNewswire Here’s Why Surgery Partners Could Be the Next Hot Takeover September 25, 2024 Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations. Via MarketBeat Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown? September 24, 2024 The FTC is going after these PBMs. Is this an opportunity for investors? Via The Motley Fool Spotlight on CVS Health: Analyzing the Surge in Options Activity September 23, 2024 Via Benzinga Is CVS Health Stock a Buy? September 22, 2024 It's been a year to forget for the healthcare company. Via The Motley Fool Behind the Scenes of CVS Health's Latest Options Trends September 11, 2024 Via Benzinga UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat? September 20, 2024 Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices. Via Benzinga Topics Lawsuit Exposures Financial Legal US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices September 20, 2024 FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access... Via Benzinga Topics Lawsuit Exposures Financial Legal Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules September 20, 2024 Eli Lilly appeals a $183 million judgment in a Medicaid fraud case, arguing that it followed a reasonable interpretation of the law. The case has drawn attention from major business and pharmaceutical... Via Benzinga Topics Fraud Exposures Legal Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields September 20, 2024 Via Benzinga What 9 Analyst Ratings Have To Say About CVS Health September 10, 2024 Via Benzinga CVS Subsidiary Oak Street Health Agrees to $60M Settlement in Medicare Kickback Violations September 19, 2024 Oak Street Health has agreed to pay $60 million to settle claims that it violated the False Claims Act by providing kickbacks to agents for recruiting seniors to its Medicare Advantage clinics,... Via Benzinga Topics Lawsuit Exposures Financial Legal 4 Dividend Stocks to Double Up On Right Now September 18, 2024 Dividend investing is a powerful way to build wealth and financial security. Via The Motley Fool CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm September 16, 2024 From Bragar Eagel & Squire Via GlobeNewswire Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims September 16, 2024 Walgreens agrees to pay $106.8 million to settle claims of false billing to federal health care programs. The settlement addresses fraudulent activities between 2009 and 2020 and includes significant... Via Benzinga Topics Lawsuit Whistleblower Exposures Financial Legal 3 Overlooked Stocks With Strong Value and Dividend Potential September 13, 2024 Three forgotten-about, sluggishly performing defensive stocks that could offer value and income potential over the long term. Via MarketBeat PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate' September 12, 2024 PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solution. Via Benzinga UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars September 11, 2024 UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. Via Benzinga CVS Shares Are Trading Lower Wednesday: What You Need To Know September 11, 2024 CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which has created a wave of uncertainty in the healthcare sector. Here's what... Via Benzinga Interest Rates, Private Equity, Stocks, Football...We've Got It All September 11, 2024 Including an interview with former NFL linebacker Brandon Copeland. Via The Motley Fool Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies September 10, 2024 Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives. Via Benzinga CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm September 10, 2024 From The Schall Law Firm Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 48 49 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
